| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 05/30/2000 | US6069144 N-heterocyclic compounds, intermediate products used to prepare them, agents containing them and their use in antifungal applications |
| 05/30/2000 | US6068845 Inhibitory activity on the abnormal production of extracellular matrices in dermal fibroblasts activated with tranforming growth factor beta by administering the plant extract of a plant belonging to the genus sophora |
| 05/30/2000 | CA1341010C Compounds useful in preparing fluorine-containing chiral smectic liquid crystals |
| 05/30/2000 | CA1341008C A - unsaturated amines, their production and use |
| 05/25/2000 | WO2000029399A1 Antiherpes compounds |
| 05/25/2000 | WO2000029378A2 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
| 05/25/2000 | CA2350742A1 Acyclic and cyclic guanidine- and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides |
| 05/24/2000 | EP1001973A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001960A1 Porous solid products of 1,3,5-benzenetricarboxylate and metal ions |
| 05/24/2000 | EP1001959A1 Method for producing bidentate monoalkyl metal complexes |
| 05/24/2000 | EP1001944A1 Pyrazine derivatives, preparation and medicines containing them |
| 05/24/2000 | EP1001930A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 05/24/2000 | EP1001927A2 Novel polyamine analogues as therapeutic and diagnostic agents |
| 05/24/2000 | EP0817767B1 Bicyclic amine derivatives and their use as anti-psychotic agents |
| 05/24/2000 | CN1254337A N-hydroxy 4-sulfonyl butyramide compounds |
| 05/24/2000 | CN1254335A Nicotinamide derivatives |
| 05/24/2000 | CN1254334A Novel terephthalamide derivatives |
| 05/24/2000 | CN1254328A Process for preparing substituted 2-3-dihydro-1-indanones |
| 05/24/2000 | CN1254197A Non-aqueous electrolyte cell |
| 05/23/2000 | US6066756 Phenylacetic acid derivatives, preparation thereof and intermediates therefor, and compositions containing them |
| 05/23/2000 | US6066730 Boronic ester and acid compounds, synthesis and uses |
| 05/23/2000 | US6066672 Of given formula comprising a substituted aminoalkyl(amido or alkylamino)alkyl(amido or alkylamino)alkyl(alkene, alkyl or alkoxycarbonyl) |
| 05/23/2000 | US6066656 2,5-diamino-3,4-disubstituted-1,6-diphenylhexane isosteres comprising benzamide, sulfonamide and anthranilamide subunits and methods of using same |
| 05/23/2000 | US6066634 Substituted condensation products of N-benzyl-3-indenylacetamides heterocyclic aldehydes for neoplasia |
| 05/23/2000 | US6066597 For crops |
| 05/23/2000 | CA2104873C Compositions and methods of treatment of sympathetically maintained pain |
| 05/18/2000 | WO2000027842A1 Compounds |
| 05/18/2000 | WO2000027820A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
| 05/18/2000 | WO2000027819A2 Antrhranilic acid amides and the use thereof as medicaments |
| 05/18/2000 | WO2000027818A1 Preparation of chloromethylpyridine hydrochlorides |
| 05/18/2000 | WO2000027805A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 05/18/2000 | WO2000027800A1 Ccr-3 receptor antagonists |
| 05/18/2000 | WO2000027795A1 Transfection reagents |
| 05/18/2000 | WO2000027792A1 Novel compounds and medicinal use thereof |
| 05/18/2000 | WO2000027790A1 Mutilin compounds |
| 05/18/2000 | WO2000027389A1 Oxy-vanadium (iv) complexes having spermicidal activity |
| 05/18/2000 | WO2000009130A3 New pharmaceutical uses for nos inhibitors |
| 05/18/2000 | WO2000004892A3 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/18/2000 | CA2350208A1 Antrhranilic acid amides and the use thereof as medicaments |
| 05/18/2000 | CA2348763A1 Novel compounds and medicinal use thereof |
| 05/18/2000 | CA2346898A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
| 05/18/2000 | CA2318162A1 Oxy-vanadium (iv) complexes having spermicidal activity |
| 05/17/2000 | EP1000938A1 Heterocyclic compounds as pharmaceuticals |
| 05/17/2000 | EP1000935A1 PYRIDYLACRYLAMIDE DERIVATIVES AND NEPHRITIS REMEDIES AND TGF-$g(b) INHIBITORS CONTAINING THE SAME |
| 05/17/2000 | EP1000934A2 Pesticidal and parasiticidal use of 1-aryl-1-(substituted thio, sulfinyl and sulfonyl)-2-nitroethane compounds |
| 05/17/2000 | EP1000932A1 Aromatic ring derivatives |
| 05/17/2000 | EP1000619A2 Method for treating glaucoma |
| 05/17/2000 | EP1000047A1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring |
| 05/17/2000 | EP1000046A1 Piperazine derivatives active on the lower urinary tract |
| 05/17/2000 | EP1000045A1 1,4-disubstituted piperazines |
| 05/17/2000 | EP1000033A1 Heterocyclic derivatives which inhibit factor xa |
| 05/17/2000 | EP1000031A1 Vitronectin receptor antagonist |
| 05/17/2000 | EP1000018A2 Urokinase inhibitors |
| 05/17/2000 | EP0999856A2 Radiopharmaceuticals for imaging infection and inflammation |
| 05/17/2000 | EP0999840A1 Use of draflazine-analogues for treating pain |
| 05/17/2000 | EP0999834A1 Antithrombotic agents |
| 05/17/2000 | EP0848701B1 O-benzyl oxime ether derivatives and their use in crop protection compositions |
| 05/17/2000 | EP0726768B1 Use of nitric oxide releasing compounds for the manufacture of a medicament for protection in ischemia reperfusion injury |
| 05/17/2000 | CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds |
| 05/17/2000 | CN1253545A Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 05/17/2000 | CN1253502A Method of using cyclooxygenase-2 inhibitors in prevention of cardiovascular disorders |
| 05/17/2000 | CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/17/2000 | CN1253019A Method for preparing medicine composition capable of inhibiting post infective virus proteinase |
| 05/16/2000 | US6063956 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides and insecticides |
| 05/16/2000 | US6063930 For treatment of neurofibromin benign proliferative disorder, retinal vascularization blindness, viral diseases, restenosis, polycystic kidney disease |
| 05/16/2000 | US6063923 Cyclization of 4-ethyl-4-hydroxy-7-(7-iodo-9-(4-methyl piperazin-1-ylmethyl)-2,3-dihydro-(1,4)dioxino(2,3-g)quinolin -8-ylmethyl)-4,7-dihydro-1h-pyrano(3,4-c)pyridine-3,8-dione, resolving mixture to yield desired enantiomer |
| 05/16/2000 | US6063816 Hydroxamic acid compounds |
| 05/16/2000 | US6063798 Substituted N-methylenethioureas as pesticides |
| 05/16/2000 | US6063541 Hydrazides |
| 05/16/2000 | CA2289827A1 Pesticidal and parasiticidal use of 1-aryl-1-(substituted thio, sulfinyl and sulfonyl)-2-nitroethane |
| 05/16/2000 | CA1340991C A-unsaturated amines, their production and use |
| 05/11/2000 | WO2000026323A1 Electrolumiscent materials |
| 05/11/2000 | WO2000026195A1 Novel amino acid heterocyclic amide derivatives useful as nitric oxide synthase inhibitors |
| 05/11/2000 | WO2000026191A1 Picolinamide derivatives and pest controllers containing the same as the active ingredient |
| 05/11/2000 | WO2000026190A1 Chiral amino alcohol derivatives of pyridine, a method for the manufacture thereof and their use as catalysts |
| 05/11/2000 | WO2000025770A1 Carbocyclic potassium channel inhibitors |
| 05/11/2000 | WO2000025767A2 Use of triphenylbutene derivatives for the treatment of neurological disorders |
| 05/11/2000 | CA2348878A1 Electroluminescent materials |
| 05/10/2000 | EP0999239A2 Heterocyclic compounds |
| 05/10/2000 | EP0999205A1 Aminocycloalkane compounds |
| 05/10/2000 | EP0999204A1 Novel compound having effect of promoting neuron differentiation |
| 05/10/2000 | EP0998473A1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 05/10/2000 | EP0998472A1 Substituted 2-(benzoaryl)pyridines |
| 05/10/2000 | EP0998459A2 Pyridine derivatives |
| 05/10/2000 | EP0998452A1 Liquid crystal propene or propenyl nitrile derivatives |
| 05/10/2000 | EP0998451A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 05/10/2000 | EP0998449A1 Method for aminating mononuclear aromatic compounds and polynuclear compounds containing at least one aromatic ring in the presence of an palladium complex catalyst |
| 05/10/2000 | EP0998283A1 Calcilytic compounds |
| 05/10/2000 | EP0998281A1 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 05/10/2000 | CN1252799A N-heterocyclic derivatives as NOS inhibitor |
| 05/10/2000 | CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 05/10/2000 | CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 05/10/2000 | CN1252693A In-situ generation of zinc pyrithione |
| 05/10/2000 | CN1052240C Method for preparing inhibitor of retroinfection viral protease |
| 05/09/2000 | US6060602 Antiallergic agent or an agent for curing allergosis |
| 05/09/2000 | US6060513 Compounds and compositions for delivering active agents |
| 05/09/2000 | US6060492 Side effect reduction |
| 05/09/2000 | US6060491 Anticoagulants; thromboembolic disorders; prophylaxis |
| 05/09/2000 | US6060484 Anti-viral method |
| 05/09/2000 | US6060476 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |